Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia - PubMed
3 hours ago
- #fibromyalgia
- #Tonmya
- #cyclobenzaprine
- Review of sublingual cyclobenzaprine (Tonmya) for fibromyalgia treatment.
- Cyclobenzaprine shows efficacy in improving daily pain scores compared to placebo.
- Common adverse effects include oral hypoesthesia, paresthesia, and abnormal taste.
- Tonmya provides a new, convenient treatment option for fibromyalgia.
- Current guidelines give weak recommendations for pharmacologic agents like duloxetine, pregabalin, and amitriptyline.